Legal & General Group PLC Summit Therapeutics Inc. Transaction History
Legal & General Group PLC
- $470 Billion
- Q3 2024
A detailed history of Legal & General Group PLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 9,719 shares of SMMT stock, worth $184,272. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,719
Previous 9,719
-0.0%
Holding current value
$184,272
Previous $212,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding SMMT
# of Institutions
193Shares Held
75.8MCall Options Held
2.01MPut Options Held
2.84M-
Baker Bros. Advisors LP New York, NY24.4MShares$463 Million5.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$208 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$150 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.44MShares$103 Million0.01% of portfolio
-
State Street Corp Boston, MA3.47MShares$65.8 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $3.82B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...